1-Methyl-D-Tryptophan Increases IDO1 in Human Cancer Cells
Author Information
Author(s): Christiane A. Opitz, Ulrike M. Litzenburger, Uta Opitz, Felix Sahm, Katharina Ochs, Christian Lutz, Wolfgang Wick, Michael Platten
Primary Institution: University Hospital of Heidelberg, Heidelberg, Germany
Hypothesis
Does the IDO inhibitor 1-methyl-D-tryptophan (1-D-MT) upregulate IDO1 expression in human cancer cells?
Conclusion
1-D-MT increases IDO1 expression in human cancer cells, which may promote tumor immune escape.
Supporting Evidence
- 1-D-MT treatment increased IDO1 mRNA and protein levels in SKOV-3 cells.
- 1-D-MT did not alter IDO1 enzymatic activity but induced its expression.
- Knockdown of IDO1 reversed the immunosuppressive effects of SKOV-3 cells on T cell proliferation.
Takeaway
A drug called 1-D-MT, used in cancer treatment, actually makes cancer cells produce more of a protein that helps them hide from the immune system.
Methodology
The study involved cell culture experiments with SKOV-3 ovarian carcinoma cells to assess the effects of 1-D-MT on IDO1 expression and kynurenine production.
Potential Biases
Potential bias due to the involvement of authors affiliated with a pharmaceutical company.
Limitations
The study primarily focused on one type of cancer cell line and may not be generalizable to all cancer types.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website